Clinical Trial Update: FMD and Neoadjuvant Chemo-immunotherapy in TNBC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FMD in combination with neoadjuvant chemo-immunotherapy for triple-negative breast cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• FMD

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING